AltaCorp Capital Initiates Coverage On Trulieve Cannabis with Outperform Rating, Announces Price Target of C$25

AltaCorp Capital initiates coverage on Trulieve Cannabis (CSE:TRUL) with a Outperform rating and announces Price Target of C$25.